Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Consequences of Prolonged Inhaled Short-acting Beta-agonist Use in Healthy Participants

NCT06027606 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT06027606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06027606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Consequences of Prolonged Inhaled Short-acting Beta-agonist Use in Healthy Participants
Lead sponsor
University of Alberta
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2023
Completion date
September 25, 2025
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy